Related Experiment Videos
Human platelets labeled with In-111 8-hydroxyquinoline: kinetics, distribution, and estimates of radiation dose
Summary
This study demonstrates that open system labeling of platelets with Indium-111 oxine (In-111) yields higher efficiency. In-111 labeled platelets are suitable for 10-day survival studies, with the spleen as the primary organ for radiation dose.
Area of Science:
- Nuclear Medicine
- Hematology
- Radiopharmacology
Background:
- Platelet survival studies are crucial for diagnosing and managing various hematological disorders.
- Indium-111 oxine (In-111) is a radiotracer used for labeling blood cells, including platelets.
- Optimizing labeling efficiency and understanding biodistribution are essential for accurate platelet kinetic studies.
Purpose of the Study:
- To compare the labeling efficiency of platelets using In-111 oxine in closed versus open systems.
- To determine the survival time, initial recovery, and biodistribution of In-111 labeled autologous platelets in normal subjects.
- To assess the radiation dose to critical organs, particularly the spleen and liver, following In-111 labeled platelet administration.
Main Methods:
- Platelet labeling with In-111 oxine in nine normal male subjects using both closed transfer packs and open test tubes.
- Quantification of initial recovery and survival time of In-111 labeled platelets using gamma-camera imaging.
- Assessment of In-111 platelet distribution in the liver, spleen, and bone marrow over several days.
Main Results:
- Open system labeling achieved a mean efficiency of 53%, significantly higher than the 27% in closed systems.
- Mean platelet survival time was 8.76 days with an initial recovery of 57%.
- The spleen accumulated 38% of the injected dose within 30 minutes, followed by the liver (13%), with bone marrow also showing accumulation. The spleen received the highest radiation dose (34 rad/mCi).
Conclusions:
- Open system labeling with In-111 oxine is more efficient for preparing platelets for kinetic studies.
- In-111 labeled platelets allow for quantitative assessment of platelet survival and organ distribution for up to 10 days.
- The spleen is identified as the critical organ for radiation dosimetry, with calculated doses supporting the feasibility of 10-day survival studies at specific In-111 activities.